Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells.
Martín-Otal C, Lasarte-Cia A, Serrano D, Casares N, Conde E, Navarro F, Sánchez-Moreno I, Gorraiz M, Sarrión P, Calvo A, De Andrea CE, Echeveste J, Vilas A, Rodriguez-Madoz JR, San Miguel J, Prosper F, Hervas-Stubbs S, Lasarte JJ, Lozano T.
Martín-Otal C, et al. Among authors: sarrion p.
J Immunother Cancer. 2022 Aug;10(8):e004479. doi: 10.1136/jitc-2021-004479.
J Immunother Cancer. 2022.
PMID: 35918123
Free PMC article.